<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<body bgcolor="#FFFFFF">
<page>
<p align="center"><font size="2" face="serif"><b>UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
WASHINGTON, DC  20549</b></font></p>
<p align="center"><font size="2" face="serif">&#150;&#150;&#150;&#150;&#150;&#150;</font></p>
<p align="center"><font size="2" face="serif"><b>FORM 8-K</b></font></p>
<p align="center"><font size="2" face="serif"><b>CURRENT REPORT<br>
</b></font><font size="2" face="serif"><b>Pursuant to Section 13 or 15(d) of the<br>
</b></font><font size="2" face="serif"><b>Securities Exchange Act of 1934</b></font></p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td colspan="2"><font size="2" face="serif">Date of Report (Date of earliest
    event reported)</font></td>
    <td><font size="2" face="serif">October 19, 2006</font></td>
  </tr>
  <tr>
    <td width="33%">&nbsp;</td>
    <td width="33%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td align="center"><font size="2" face="serif"><b><u>DATASCOPE CORP.</u></b></font></td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td colspan="3" align="center"><font size="2" face="serif">(Exact name of registrant as specified in
    its charter)</font> </td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td align="center"><font size="2" face="serif"><u>Delaware</u></font></td>
    <td align="center"><font size="2" face="serif"><u>0-6516</u></font></td>
    <td align="center"><font size="2" face="serif"><u>13-2529596</u></font></td>
  </tr>
  <tr>
    <td align="center"><font size="2" face="serif">(State or other jurisdiction</font></td>
    <td align="center"><font size="2" face="serif">(Commission</font></td>
    <td align="center"><font size="2" face="serif">(IRS Employer</font></td>
  </tr>
  <tr>
    <td align="center"><font size="2" face="serif">of incorporation)</font></td>
    <td align="center"><font size="2" face="serif">File
Number)</font></td>
    <td align="center"><font size="2" face="serif">Identification No.)</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td align="center"><font size="2" face="serif">14 Philips Parkway<br>
    <u>Montvale, New Jersey</u></font></td>
    <td>&nbsp;</td>
    <td align="center" valign="bottom"><font size="2" face="serif"><u>07645-9998</u></font></td>
  </tr>
  <tr>
    <td align="center"><font size="2" face="serif">(Address of principal executive offices)</font></td>
    <td>&nbsp;</td>
    <td align="center"><font size="2" face="serif">(Zip Code)</font></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td colspan="2"><font size="2" face="serif">(Registrant's telephone number, including
    area code)</font></td>
    <td align="center"><font size="2" face="serif"><u>(201) 391-8100</u></font></td>
  </tr>
</table>

<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></p>
<p align="left"><font size="2" face="serif"><img src="emptybox.gif">&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>
<p align="left"><font size="2" face="serif"><img src="emptybox.gif">&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p align="left"><font size="2" face="serif"><img src="emptybox.gif">&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p align="left"><font size="2" face="serif"><img src="emptybox.gif">&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p align="center"><font face="serif" size="2"></font></p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p align="left"><font size="2" face="serif">Item 2.05&nbsp;&nbsp;&nbsp;Costs Associated with Exit or Disposal Activities</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
    October 19, 2006, Datascope Corp. announced its decision to exit the vascular
    closure market and phase out its Interventional Products business and most
    of the workforce of that business by fiscal year-end, as described in the
press release attached as Exhibit 99.1.</font></p>
<p align="left"><font size="2" face="serif">Item 9.01</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibits:</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="6%"><font size="2" face="serif">&nbsp;</font></td>
<td width="10%"><font size="2" face="serif">Exhibit 99.1</font></td>
<td align="left"><font size="2" face="serif">Press release announcing the decision
    of Datascope Corp. to exit the vascular closure
    market and phase out its Interventional Products business and most of the
    workforce of that business by fiscal year-end, dated October 19, 2006.</font></td>
</tr>
</table>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p><a href="#contents"><font size="2">Back to Contents</font></a></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif">SIGNATURES</font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="50%"><font size="2" face="serif">&nbsp;</font></td>
<td colspan="2"><font size="2" face="serif">&nbsp;</font><font size="2" face="serif">DATASCOPE CORP.</font></td>
</tr>
<tr valign="top">
<td><font size="2" face="serif">&nbsp;</font></td>
<td colspan="2"><font size="2" face="serif">&nbsp;</font><font size="2" face="serif">Registrant</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
  <td width="4%">&nbsp;</td>
  <td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td><font size="2" face="serif">&nbsp;</font></td>
<td><font size="2" face="serif">By:</font></td>
<td align="left"><font size="2" face="serif"><u> /s/ Scott D. Kantor&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></font></td>
</tr>
<tr valign="top">
<td><font size="2" face="serif">&nbsp;</font></td>
<td><font size="2" face="serif">&nbsp;</font></td>
<td align="left"><font size="2" face="serif">Vice President, Finance and<br>
  Administration, and<br>
  Chief Financial Officer</font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">Dated:  October 23, 2006</font></p>
<p align="center">&nbsp;</p>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<a name="p?"></a>
<p>&nbsp;</p>
<p align="center"><font size="2" face="serif">EXHIBIT INDEX</font></p>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td width="10%"><font size="2" face="serif">Exhibit 99.1</font></td>
<td align="left"><font size="2" face="serif">Press release announcing the decision
    of Datascope Corp. to exit the vascular closure
    market and phase out its Interventional Products business and most of the
    workforce of that business by fiscal year-end, dated October 19, 2006.</font></td>
</tr>
</table>
<p align="center"><font face="serif" size="2"></font></p>
<hr noshade align="center" width="100%" size="2">

</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "b415389_8k.htm", "description": "FORM 8K", "secsgml_size_bytes": 8090}]
{"company-data": {"conformed-name": "DATASCOPE CORP", "cik": "0000027096", "assigned-sic": "3845", "irs-number": "132529596", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-06516", "film-number": "061160616"}, "business-address": {"street1": "14 PHILLIPS PKWY", "city": "MONTVALE", "state": "NJ", "zip": "07645-9998", "phone": "2013918100"}, "mail-address": {"street1": "14 PHILIPS PARKWAY", "city": "MONTVALE", "state": "NJ", "zip": "07645"}}
Prepared and filed by St Ives Financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
––––––
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest
    event reported)
October 19, 2006
DATASCOPE CORP.
(Exact name of registrant as specified in
    its charter)
Delaware
0-6516
13-2529596
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File
Number)
Identification No.)
14 Philips Parkway
Montvale, New Jersey
07645-9998
(Address of principal executive offices)
(Zip Code)
(Registrant's telephone number, including
    area code)
(201) 391-8100
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.05   Costs Associated with Exit or Disposal Activities
On
    October 19, 2006, Datascope Corp. announced its decision to exit the vascular
    closure market and phase out its Interventional Products business and most
    of the workforce of that business by fiscal year-end, as described in the
press release attached as Exhibit 99.1.
Item 9.01
(c)      Exhibits:
Exhibit 99.1
Press release announcing the decision
    of Datascope Corp. to exit the vascular closure
    market and phase out its Interventional Products business and most of the
    workforce of that business by fiscal year-end, dated October 19, 2006.
Back to Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DATASCOPE CORP.
Registrant
By:
/s/ Scott D. Kantor
Vice President, Finance and
Administration, and
Chief Financial Officer
Dated:  October 23, 2006
EXHIBIT INDEX
Exhibit 99.1
Press release announcing the decision
    of Datascope Corp. to exit the vascular closure
    market and phase out its Interventional Products business and most of the
    workforce of that business by fiscal year-end, dated October 19, 2006.